Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
A prescription drug diversion monitoring app for multi-generational households tracking controlled substance handling to prevent in-family theft.
AI Thinking Process
Scale Shift from hospital pharmacy diversion detection: institutional drug diversion detection uses dispensing anomaly analysis to identify staff theft. Consumer analog: multi-generational households with elderly members on opioids or controlled substances, where adult children or caregivers may divert. Market: 6.7M households managing elderly parent prescriptions with in-home controlled substances.
Severe identity conflict detected: the buyer (adult child or household manager) must publicly acknowledge they suspect in-family theft to purchase and deploy this product. The buyer is inside the trust circle of the monitored behavior. This is not a stigma-as-friction problem — it is a structural adoption barrier because using the app is itself a public accusation of a family member.
KILLED: structural adoption barrier. Assisted living pivot: PointClickCare and MatrixCare already have diversion detection modules for facilities. Scale Shift fails when buyer is inside the trust circle of the behavior being monitored. New nuance for Scale Shift rule: institutional-to-consumer fails when buyer must publicly name in-group misbehavior.
Kill Reason
Severe identity conflict — the product asks the buyer to publicly acknowledge an in-family theft hypothesis. The buyer is inside the trust circle of the behavior being monitored, creating a structural adoption barrier. Assisted living facility pivot occupied by PointClickCare and MatrixCare.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Passive voice-based depression detection requires FDA Software as a Medical Device clearance for any diagnostic claim; a "wellness" framing undercuts the core value proposition and reduces willingness to pay. Epic Systems and large telehealth platforms are already integrating validated mental health screening tools into clinical workflows, crowding out standalone apps before they achieve scale.
killed: Google Nest Hub's built-in Soli radar-based sleep sensing already delivers contactless respiratory monitoring in millions of households, and Withings has shipped FDA-cleared sleep apnea screening hardware. A standalone $30 WiFi module cannot match the distribution, brand trust, or regulatory standing of these well-resourced incumbents.
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.